Newsroom

Research Highlights

NIA Media Contacts

Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov

  • Researchers find genetic influences on memory performance in familial AD
    July 16, 2004

    Genetics may influence memory performance in families with a history of Alzheimer’s Disease according to researchers writing in the February 10, 2004 issue of Neurology. Previous human genetic studies focusing on memory have been...

  • Researchers find genetic influences on memory performance in familial AD
    July 16, 2004

    Genetics may influence memory performance in families with a history of Alzheimer’s Disease according to researchers writing in the February 10, 2004 issue of Neurology. Previous human genetic studies focusing on memory have been...

  • Using marketing principles to improve clinical trial recruitment
    April 1, 2004

    Successfully recruiting participants for clinical trials is a challenge that crosses all medical disciplines, but is particularly difficult in the field of Alzheimer’s disease (AD) research. The nature of the disease, the need to...

  • Using marketing principles to improve clinical trial recruitment
    April 1, 2004

    Successfully recruiting participants for clinical trials is a challenge that crosses all medical disciplines, but is particularly difficult in the field of Alzheimer’s disease (AD) research. The nature of the disease, the need to...

  • New neuroimaging and biomarkers in MCI and AD initiative
    August 1, 2003

    A new National Institute on Aging (NIA) initiative will launch a multi-year neuroimaging study using serial magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to examine how brains change as mild cognitive...

  • Alzheimer's disease and end-of-life issues
    August 1, 2003

    Despite our best research efforts, Alzheimer's disease remains incurable. Researchers are using sophisticated technologies to pinpoint how AD progressively steals memories and destroys personality; and yet, AD remains irreversible....

  • End-of-life legal instruments
    August 1, 2003

    What sets Alzheimer's disease apart from many other terminal diseases is the progressive, irreversible loss of cognitive abilities, which begins early and becomes increasingly worse. The majority of patients arrive at the later stages...

  • New neuroimaging and biomarkers in MCI and AD initiative
    August 1, 2003

    A new National Institute on Aging (NIA) initiative will launch a multi-year neuroimaging study using serial magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to examine how brains change as mild cognitive...

  • Alzheimer's disease and end-of-life issues
    August 1, 2003

    Despite our best research efforts, Alzheimer's disease remains incurable. Researchers are using sophisticated technologies to pinpoint how AD progressively steals memories and destroys personality; and yet, AD remains irreversible....

  • End-of-life legal instruments
    August 1, 2003

    What sets Alzheimer's disease apart from many other terminal diseases is the progressive, irreversible loss of cognitive abilities, which begins early and becomes increasingly worse. The majority of patients arrive at the later stages...

Pages